A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

Late-stage GLP-1 candidates from Eli Lilly, Novo Nordisk and Amgen have a combined net present value of $68 billion.

Additional benefits seen for diastolic blood pressure and concentrations of triglycerides and aspartate aminotransferase.

Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.

Future GLP-1 gene therapy could enable long-term hormone production, with Fractyl Health and others planning human trials in 2024.

Stopping GLP-1 weight loss drugs like Ozempic and Wegovy often leads to rapid weight regain and returning health risks.

Losing weight is best done with medical supervision.

As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% meeting criteria for obesity alone, according to the Centers for Disease Control ...

In clinical trials, weight loss with GLP-1 medications tends to follow a predictable curve: rapid early losses during drug ...